Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RayzeBio
Biotech
Candid flashes big ambitions with $370M debut
Candid’s launch combines fundraising and the acquisition of two biotechs, Vignette Bio and TRC 2004, along with their lead assets.
Darren Incorvaia
Sep 9, 2024 9:00am
Top 10 smartest deals in biopharma
Jun 24, 2024 6:00am
BMS more likely to bet on bolt-ons after recent buying spree
Feb 2, 2024 10:59am
BMS beat 2 other pharmas in bid for RayzeBio
Jan 25, 2024 1:35pm
Christmas deal spree: See what J&J, Roche had in their stockings
Jan 2, 2024 7:35am
BMS enters radiopharma race with $4.1B acquisition of RayzeBio
Dec 27, 2023 5:36am
